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The uptake of ‘251-labeled epidermal growth factor (‘251-EGF) by mouse pancreatic acini was inhibited 
(40-50%) by the secretagogue cholecystokinin octapeptide (CCKs). Analysis of competitive binding data 
showed that the apparent Kd of EGF binding increased 135% while the binding capacity was only slightly 
altered (30% increase). That the effect of CCKs on acini was mediated by intracellular Ca2+ was indicated 
by the following: (i) Inhibition of “‘I-EGF binding to acini was dose-dependent and paralleled the known 
abilities of CCKs, its analogs, and the cholinergic secretagogue carbachol to induce Ca2+ efflux from acini; 
and (ii) addition of the Ca2+ ionophore A23 187 also inhibited “‘1-EGF binding. In addition, EGF 
association with A431 cells was also inhibited by A23187 in the presence but not the absence of Ca’+. 
EGF Calcium 
1. INTRODUCTION 
We and others have recently reported that pan- 
creatic acini possess EGF receptors [1,2] and that 
EGF promotes the maintenance of differentiated 
acinar cell function in culture [ 1,3]. In the course 
of these studies we found that cholecystokinin 
(CCK), a polypeptide hormone structurally 
unrelated to EGF, inhibited the uptake of ‘*‘I- 
EGF by these cells. Uptake or association of ‘*‘I- 
EGF with cells or membrane will by convention be 
referred to as ‘binding’. This is used as an opera- 
tional definition and does not indicate the state of 
cell-associated hormone. A preliminary report of 
these results has appeared in the proceedings of the 
74th Annual Meeting of the American Society of 
Biological Chemists (Fed. Proc. 42, 1905). All of 
the major effects of CCK are believed to be 
mediated by an increase in free intracellular Ca*+ 
[4-61. Here, we have therefore investigated the in- 
hibitory effect of CCK on 1251-EGF binding to 
pancreatic acini to determine whether this effect is 
also mediated by intracellular Ca*+. In addition, 
Receptor Pancreas 
we have studied A43 1 human epidermal carcinoma 
cells, a model cell type for studying EGF receptors. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
Isolated mouse pancreatic acini from fed adult 
male Swiss Webster mice were prepared and 
cultured as in [l]. Acini were incubated as suspen- 
sion cultures in Waymouths medium containing 
20 mM Hepes buffer, 100 units/ml penicillin, 
100 pug/ml streptomycin, 0.2 mg/ml soybean tryp- 
sin inhibitor, and 20% fetal bovine serum at 37°C. 
All experiments on acini were conducted after 24 h 
of culture. 
A431 cells were propagated in DME-H21 
medium containing 10% heat inactivated fetal 
bovine serum, penicillin, and streptomycin, at 
37°C. 
2.2. Binding studies 
EGF (Collaborative 
grade) was iodinated 
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by a version of the 
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chloramine-T method [ 11. Pancreatic acini 
(0.1-0.2 mg acinar protein/ml) were washed free 
of culture medium and resuspended in a Hepes- 
buffered Ringer (HR) enriched with minimal 
Eagle’s medium amino acid supplement, soybean 
trypsin inhibitor (0.1 mg/ml), 0.5% bovine serum 
albumin, and gassed with 100% OZ. “‘1-EGF 
(40-60 PM) plus various concentrations of 
unlabeled hormones and secretagogues were added 
to the suspension and incubated in a shaking water 
bath at 37°C. At specific times triplicate l-ml 
samples of the suspension were removed and cen- 
trifuged at 300 x g for 2 min at 4°C. The superna- 
tant was sampled to determine total counts, and 
the pellets were washed twice with 0.15 M NaCl at 
4°C. Radioactivity associated with the washed 
acinar pellets was measured in a gamma scintilla- 
tion counter, and the acinar protein measured [7]. 
Non-specific binding was determined in the 
presence of an excess of unlabeled EGF (100 nM). 
Competitive inhibition of specific 1251-EGF uptake 
by various concentrations of unlabeled EGF was 
analyzed by fitting plots of bound hormone vs free 
hormone with a non-linear least squares computer 
program which calculated the affinity and capacity 
of the EGF binding site [8]. 
For binding to A431 cells, cells were plated onto 
35-mm dishes at 1 x lo5 cells/dish 48 h prior to the 
beginning of the experiment. Culture medium was 
replaced with 2 ml of HR pre-warmed to 37°C and 
12’1-EGF, non-radioactive EGF, and secretagogues 
were added at various concentrations. Plated cells 
were incubated at 37°C for 1 h. The dishes were 
then washed twice in ice-cold 0.15 M saline and the 
cells removed by scraping into 1 ml of 0.1 N 
NaOH in saline. Cell-bound radioactivity was 
determined and the protein content of each sample 
(50-100 pg) was measured. 
Degradation of labeled hormone in the medium 
was determined by precipitation of binding super- 
natants with trichloroacetic acid added at a final 
concentration of 10%. 
3. RESULTS 
3.1. Effects of CCKa on EGF binding to 
pancreatic acini 
Cultured acini incubated with 50 pM 1251-EGF 
at 37°C for 2 h bound an average of 13.6 * 1.3% 
(n = 10) of total radioactivity per mg protein, while 
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non-saturable binding represented only 4% of 
total binding (0.6 + 0.1% bound/mg protein). The 
effect of increasing concentrations of CCKg or 
EGF on the specific binding of “‘I-EGF to pan- 
creatic acini is shown in fig. 1. CCKg inhibited EGF 
binding in a dose-dependent manner with signifi- 
cant inhibition present at 100 pM and a maximal 
inhibition of 42.2 f 2.6% (n = 6) occurring with 
3 nM CCKg. Higher concentrations of CCKg did 
not further inhibit 12’1-EGF binding. By contrast, 
inhibition of “‘1-EGF binding by non-radioactive 
EGF increased with increasing concentrations until 
inhibition was maximal at 100 nM. CCKg had no 
effect on non-specific ‘251-EGF binding determin- 
ed in the presence of 100 nM EGF. Dibutyryl 
cGMP, a competitive antagonist of CCK [9], had 
no effect on specific or non-specific EGF binding 
when tested alone, but completely blocked the 
CCK-induced inhibition of EGF binding. 
To test whether CCKg increased the degradation 
of ‘251-EGF, we measured the trichloroacetic acid 
precipitability of the lZ51-EGF in the binding 
medium. Equal low levels of degradation averag- 
ing 4.4 + 0.5% (n = 8) were found after 2 h of in- 
cubation with acini in the presence or absence of 
10 nM CCKs. 
3.2. Dose-response for inhibition of EGF binding 
by other &+-mediated secretagogues 
Other Ca2+-mediated secretagogues were tested 
for their effects on ‘251-EGF binding. Fig.2 shows 
100 
l--k CCK* + mcGMP f 
J 
Fig.1. Effects of various concentrations of EGF, CCKg 
and CCKs plus 1 mM dbcGMP on the specific binding 
of “‘1-EGF to pancreatic acini. Binding was carried out 
at 37°C for 2 h after simultaneous addition of tracer and 
EGF (o), CCKs (A), or CCKs plus 1 mM dbcGMP (A). 
Results are plotted as a % of control value and are the 
means + SEM of 6 experiments. 
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Fig.2. Inhibition of specific “‘1-EGF binding to acini by 
scretagogues whose actions are mediated by calcium. 
Acini (0.1-0.2 mg protein/ml) were incubated at 37°C 
for 2 h in the presence of 50 pM ‘**I-EGF and varying 
concentrations of CCKs (o), desulfated CCKs (0), 
A23187 (m), or carbachol (0). Results are plotted as a 
070 of control value and are the means + SEM of 6 
experiments. 
that CCKs, desulfated CCKs and carbachol in- 
hibited the association of “‘I-EGF with acini. 
Desulfated CCKs is 200-times weaker than CCKs, 
in concert with its known ability to bind to the 
CCK receptor on pancreatic plasma membranes 
[lo]. Thus inhibition occurred over concentration 
ranges paralleling the known ability of these 
secretagogues to mediate Ca2+ efflux from pan- 
creatic acini and stimulate amylase release. The 
Ca2+ ionophore A23187, which by-passes recep- 
tors but mimics the effects of these secretagogues 
on acinar cell function by directly increasing in- 
tracellular CL’+, also inhibited 12’1-EGF associa- 
tion (fig.2). In contrast to these data for binding to 
whole cells, 12*1-EGF binding to acinar membrane 
preparations was not affected by the concentra- 
tions of Ca2+ in the medium in either the presence 
or absence of CCKs (not shown). 
3.3. Effects of &+-mediated secretagogues on 
EGF binding to A431 cells 
We also measured ‘251-EGF binding to cultures 
of A431 cells, a cell line which has an unusually 
high number of EGF receptors [l 11. The effects of 
CCKg, carbachol, and A23187 on lZ51-EGF bin- 
ding to A43 1 cells is shown in table 1. CCKg and 
carbachol had no effect on EGF binding to these 
cells. In contrast, A23187 significantly inhibited 
Table 1 
Effects of secretagogues on lz51-EGF binding to A431 
E cells 
Condition “‘1-EGF bound 
070 control 
CCKs (10 nM) 
Carbachol (1 mM) 
A23187 (5 PM), without Ca’+ 
A23187 (5 PM), plus Ca2+ 
95.2 + 13.5 (3) 
100.1 f 15.0 (2) 
104.7 + 15.0 (2) 
(1.25 mM) 60.2 f 10.0 (6) 
Cultures were incubated at 37°C for 1 h with 100 pM 
“‘1-EGF in the presence or absence of the various 
secretagogues. The Ca2+ concentration in the medium 
was 1.25 mM unless otherwise noted. Each value 
represents the mean + SD of 1251-EGF binding expressed 
as a % of control binding for the number of experiments 
given in parentheses 
EGF binding by 40 f 4% (n = 6) in the presence, 
but not the absence of Ca2+ in the binding 
medium. The absence of medium Ca2+ did not 
decrease the level of inhibition of EGF binding to 
acini induced by secretagogues (not shown). Since 
these secretagogues are able to increase in- 
tracellular free Ca2’ by causing release from in- 
tracellular pools, and this increase is sufficient to 
elicit most of the actions of these agents on acini 
[4], it is reasonable to assume that intracellular 
Ca2+ release also accounts for secretagogue- 
induced inhibition of EGF binding to acini in the 
absence of medium Ca’+. 
3.4. Effect of EGF concentrations on inhibition 
of “‘1-EGF binding to pancreatic acini and 
A431 cells 
Competitive inhibition curves of 1251-EGF bin- 
ding to pancreatic acini were carried out with vary- 
ing concentrations of unlabeled EGF in the 
presence and absence of CCKs (fig.3a). The in- 
hibitory effects of CCKs were much greater at 
lower concentrations of ligand. Computer analyses 
of competitive inhibition curves indicated that the 
inhibition of “‘1-EGF binding by CCKs occurred 
with little change in maximal binding of EGF (30 
+- 6% increase, n = 3) while the concentration of 
EGF required for half-maximal binding was more 
than doubled from 0.4 in the control to 1 .O nM in 
the presence of CCKg (135 f 8% increase). Thus 
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Fig.3. Competition-inhibition curves of “‘I-EGF 
binding to pancreatic acini and A43 1 cells. (a) Binding to 
acini in the presence and absence of CCKs. (b) Binding 
to A431 cells in the presence and absence of A23187. 
Unlabeled EGF concentrations range from 0 to 100 nM; 
binding in the presence of 100 nM EGF was considered 
non-specific and subtracted from the other values. 
Incubations were carried out at 37°C for 2 h in the case 
of acini, or for 1 h in the case of A431 cells. Results 
shown are representative of 2-4 experiments. 
CCKs leads to an apparent decrease in EGF recep- 
tor affinity. 
A competition-inhibition curve for EGF binding 
to A43 1 cells in the presence or absence of A23 187 
plus Ca2+ is shown in fig.3b. The effects of A23187 
were also greater at lower EGF concentrations and 
no change in maximal binding was noted. The con- 
centration of non-radioactive EGF reauired for 
half-maximal inhibition of “‘1-EGF binding was 
doubled from 2.5 nM in the control to 5 nM in the 
presence of A23187 plus Ca’+. 
4. DISCUSSION 
The experiments presented here show that 
CC&, desulfated CCKs, carbachol and the 
ionophore A23187 inhibit the association of ‘251- 
EGF with pancreatic acini. Several lines of 
evidence suggest hat this inhibition is not due to a 
direct competition for EGF receptors: 
(0 
(ii) 
(iii) 
(iv) 
These pancreatic secretagogues are chemically 
diverse, and are structurally unrelated to EGF; 
Inhibition of ‘251-EGF binding is incomplete 
even at maximal doses of these agents; 
CCKs, the most potent inhibitor, had no ef- 
fect on EGF binding to acinar membrane 
particles; 
Neither CCKs nor carbachol inhibited 1251- 
EGF binding to its receptor on A431 cells 
(which do not have CCK and muscarinic 
receptors). 
It is highly probable that the inhibitory effects of 
these secretagogues are mediated by intracellular 
calcium. Support for this hypothesis comes from 
the following observations: 
(9 
(ii) 
(iii) 
(iv) 
Intracellular levels of Ca2+ in pancreatic 
acinar cells are increased by CCKs, carbachol 
and A23187 [4,6,12]; 
All major effects of these secretagogues on 
pancreatic acinar cells are believed to be 
mediated by Ca2+ [4-61; 
The relative potencies of each secretagogue on 
inhibition of 1251-EGF binding is in parallel 
with its ability to cause Ca2+ efflux from acini 
[12,131; 
the Ca2+ ionophore A23 187 inhibited EGF 
binding to A431 cells in the presence but not 
in the absence of medium Ca2+. 
The observed inhibition of EGF binding occur- 
red as an apparent affinity change. While this 
could indicate an effect of intracellular calcium on 
the affinity of the EGF receptor, association of 
EGF and other ligands with their target cells in- 
volves a complex series of events including bin- 
ding, internalization and processing [14]. The in- 
hibition of “‘1-EGF association with acini and 
A431 cells could therefore result from an effect of 
calcium on any of these events. 
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